{
    "nct_id": "NCT02006654",
    "title": "Randomised, Double-blind, Parallel-group, Placebo-controlled Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor",
    "status": "COMPLETED",
    "last_update_time": "2018-01-12",
    "description_brief": "To establish efficacy of idalopirdine as adjunctive therapy to acetylcholinesterase inhibitors (AChEIs) for symptomatic treatment of patients with mild-moderate Alzheimer's disease (AD).",
    "description_detailed": "The study consisted of a screening period (up to 2-week period from screening to randomization), a 24-week double-blind treatment period with placebo or idalopirdine 60mg/day as adjunctive therapy to an acetylcholinesterase inhibitor (donepezil 10mg/day, rivastigmine at the patient's individual maintenance dose, or galantamine at the patient's individual maintenance dose), and a 4-week safety follow-up period following study completion or withdrawal from treatment. The dose could be decreased once during the study to 30mg/day if 60mg/day was not well tolerated in the opinion of the investigator. The dose could be increased again to 60mg/day, after which the dose was kept fixed for the remainder of the study. Dose changes were permitted until Week 12 (Visit 5).",
    "phase": [
        "PHASE3"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "TREATMENT",
    "results": {
        "participantFlowModule": {
            "groups": [
                {
                    "id": "FG000",
                    "title": "Placebo",
                    "description": "Placebo adjunct to base treatment with an AChEI\n\nPlacebo: Once daily, matching placebo capsules, orally"
                },
                {
                    "id": "FG001",
                    "title": "Idalopirdine 60 mg (or 30 mg)",
                    "description": "Idalopirdine adjunct to base treatment with an ACHEI\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                }
            ],
            "periods": [
                {
                    "title": "Overall Study",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "369"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "365"
                                }
                            ]
                        },
                        {
                            "type": "Treated",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "365"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "363"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "324"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "321"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "45"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "44"
                                }
                            ]
                        }
                    ],
                    "dropWithdraws": [
                        {
                            "type": "Withdrawal before treatment",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "4"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "2"
                                }
                            ]
                        },
                        {
                            "type": "Adverse Event",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "16"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "17"
                                }
                            ]
                        },
                        {
                            "type": "Death",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "Withdrawal by Subject",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "14"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "12"
                                }
                            ]
                        },
                        {
                            "type": "Protocol Violation",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "5"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "8"
                                }
                            ]
                        },
                        {
                            "type": "Lost to Follow-up",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "patient's will",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "2"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                }
                            ]
                        },
                        {
                            "type": "insufficient compliance",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "worsening cognitive condition",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                }
                            ]
                        },
                        {
                            "type": "faecal incontinence",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                }
                            ]
                        },
                        {
                            "type": "mood disorder",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                }
                            ]
                        },
                        {
                            "type": "disallowed medication",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "moving out of state",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "populationDescription": "A total of 734 patients were randomized into the study but 6 patients were not treated (did not receive IMP). The baseline analysis population only consist of patients who have been treated.",
            "groups": [
                {
                    "id": "BG000",
                    "title": "Placebo",
                    "description": "Placebo adjunct to base treatment with an AChEI\n\nPlacebo: Once daily, matching placebo capsules, orally"
                },
                {
                    "id": "BG001",
                    "title": "Idalopirdine 60 mg (or 30 mg)",
                    "description": "Idalopirdine adjunct to base treatment with an AChEI\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                },
                {
                    "id": "BG002",
                    "title": "Total",
                    "description": "Total of all reporting groups"
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "365"
                        },
                        {
                            "groupId": "BG001",
                            "value": "363"
                        },
                        {
                            "groupId": "BG002",
                            "value": "728"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Continuous",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "years",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "74.2",
                                            "spread": "8.0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "73.6",
                                            "spread": "8.6"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "73.9",
                                            "spread": "8.3"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "131"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "135"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "266"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "234"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "228"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "462"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Ethnicity (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Hispanic or Latino",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "8"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "14"
                                        }
                                    ]
                                },
                                {
                                    "title": "Not Hispanic or Latino",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "33"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "33"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "66"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "324"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "324"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "648"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Race (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "American Indian or Alaska Native",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "NA",
                                            "comment": "Information has not been collected"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "NA",
                                            "comment": "Information has not been collected"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "NA",
                                            "comment": "Total not calculated because data are not available (NA) in one or more arms."
                                        }
                                    ]
                                },
                                {
                                    "title": "Asian",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "40"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "39"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "79"
                                        }
                                    ]
                                },
                                {
                                    "title": "Native Hawaiian or Other Pacific Islander",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Black or African American",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "12"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "7"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "19"
                                        }
                                    ]
                                },
                                {
                                    "title": "White",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "292"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "299"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "591"
                                        }
                                    ]
                                },
                                {
                                    "title": "More than one race",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "NA",
                                            "comment": "Information has not been collected"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "NA",
                                            "comment": "Information has not been collected"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "NA",
                                            "comment": "Total not calculated because data are not available (NA) in one or more arms."
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "21"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "18"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "39"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Region of Enrollment",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "title": "Singapore",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "17"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "15"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "32"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "United States",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "41"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "39"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "80"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Czechia",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "42"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "37"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "79"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "United Kingdom",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "7"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "11"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Switzerland",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "4"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Spain",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "65"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "62"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "127"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "South Korea",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "19"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "20"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "39"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Turkey",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "15"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "14"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "29"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Brazil",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "23"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "21"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "44"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Mexico",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "25"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "23"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "48"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Slovakia",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "27"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "29"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "56"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Israel",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "7"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "9"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "16"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Australia",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "19"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "23"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "42"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Germany",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "37"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "43"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "80"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "France",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "9"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "11"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "20"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "MMSE total score at screening",
                    "description": "Measure Description: The Mini Mental State Examination (MMSE) is an 11-item test to assess the cognitive aspects of mental function. The subtests assess orientation, memory, attention, language, and visual construction. The scores for each item is dichotomous (1 = response is correct, 0 = response is incorrect). Total score of the 11 items ranges from 0 to 30 (higher score indicates lower deficit).",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "units on a scale",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "17.5",
                                            "spread": "3.0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "17.2",
                                            "spread": "2.9"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "17.3",
                                            "spread": "2.9"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "Change in Cognition",
                    "description": "Change from baseline to Week 24 in Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog) total score.\n\nThe Alzheimer's Disease Assessment Scale - Cognitive subscale (ADAS-cog) is a 11-item neuropsychological test that assess the severity of cognitive impairment. The items determine the patient's orientation, memory, language, and praxis. Total score of the 11 items range from 0 to 70 (lower score indicates lower cognitive impairment).",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine, and who had a valid baseline assessment and at least one valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure assessed.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline and Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to base treatment with an AChEI\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 60 mg (or 30 mg)",
                            "description": "Idalopirdine adjunct to base treatment with an ACHEI\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "356"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "361"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.68",
                                            "spread": "0.37"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.13",
                                            "spread": "0.38"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "groupDescription": "For demonstrating efficacy, change in cognition (ADAS-cog) and either change in daily functioning (ADCS-ADL23) or change in global clinical impression (ADCS-CGIC) had to show statistically significant favourable differences compared to placebo at Week 24. Multiple testing procedures were used to control the overall type 1 error at 5%. The null hypothesis of no difference in mean change from baseline in ADAS-cog total score at Week 24 was tested for idalopirdine at significance level 5%.",
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.2365",
                            "pValueComment": "Corrected for multiplicity",
                            "statisticalMethod": "Mixed Models Analysis",
                            "statisticalComment": "Adjusted for effects of country, MMSE stratum-by-week, treatment-by-week, base treatment stratum-by-week, and baseline score-by-week interactions",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "-0.55",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-1.45",
                            "ciUpperLimit": "0.36",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.46",
                            "estimateComment": "A negative mean difference indicates a treatment effect in favor of idalopirdine"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Global Impression",
                    "description": "Alzheimer's Disease Cooperative Study - Clinical Global Impression of Change (ADCS-CGIC) score at Week 24.\n\nThe Alzheimer's Disease Cooperative Study - Clinical Global Impression of Change is a semi-structured interview to assess clinically relevant changes in patients with AD. The items determine cognition, behavior, social and daily functioning. Severity at baseline is rated on a 7-point scale from 1 (normal, not ill at all) to 7 (among the most extremely ill patients). The clinically relevant change from baseline is rated on a 7-point scale from 1 (marked improvement) to 7 (marked worsening).",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine, and who had a valid baseline assessment and at least one valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure assessed.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline and Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to base treatment with an AChEI\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 60 mg (or 30 mg)",
                            "description": "Idalopirdine adjunct to base treatment with an ACHEI\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "353"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "357"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "4.32",
                                            "spread": "0.07"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "4.39",
                                            "spread": "0.07"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "groupDescription": "For demonstrating efficacy, change in cognition (ADAS-cog) and either change in daily functioning (ADCS-ADL23) or change in global clinical impression (ADCS-CGIC) had to show statistically significant favourable differences compared to placebo at Week 24. Multiple testing procedures were used to control the overall type 1 error at 5%. The null hypothesis of no difference in mean change from baseline in ADAS-cog total score at Week 24 was tested at significance level 5%.",
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.4064",
                            "pValueComment": "Corrected for multiplicity according to the multiple testing procedure",
                            "statisticalMethod": "Mixed Models Analysis",
                            "statisticalComment": "Adjusted for effects of country, MMSE stratum-by-week, treatment-by-week, base treatment stratum-by-week, and baseline score-by-week interactions",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "0.07",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.09",
                            "ciUpperLimit": "0.23",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.08",
                            "estimateComment": "A negative mean difference indicates a treatment effect in favor of idalopirdine"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Daily Functioning",
                    "description": "Change from baseline to Week 24 in Alzheimer's Disease Cooperative Study - Activities of Daily Living Inventory (ADCS-ADL23) total score.\n\nThe Alzheimer's Disease Cooperative Study - Activities of Daily Living (ADCS-ADL23) is a 23-item clinician-rated inventory to assess activities of daily living (conducted with a caregiver or informant). Each item comprises a series of hierarchical sub-questions, ranging from the highest level of independent performance to a complete loss for each activity. Total score of the 23 items ranges from 0 to 78 (higher score indicates lower disability).",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine, and who had a valid baseline assessment and at least one valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure assessed.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline and Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to base treatment with an AChEI\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 60 mg (or 30 mg)",
                            "description": "Idalopirdine adjunct to base treatment with an ACHEI\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "356"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "361"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-1.72",
                                            "spread": "0.50"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-1.05",
                                            "spread": "0.51"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "groupDescription": "For demonstrating efficacy, change in cognition (ADAS-cog) and either change in daily functioning (ADCS-ADL23) or change in global clinical impression (ADCS-CGIC) had to show statistically significant favourable differences compared to placebo at Week 24. Multiple testing procedures were used to control the overall type 1 error at 5%. The null hypothesis of no difference in mean change from baseline in ADAS-cog total score at Week 24 was tested at significance level 5%.",
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.4064",
                            "pValueComment": "Corrected for multiplicity according to the multiple testing procedure",
                            "statisticalMethod": "Mixed Models Analysis",
                            "statisticalComment": "Adjusted for effects of country, MMSE stratum-by-week, treatment-by-week, base treatment stratum-by-week, and baseline score-by-week interactions",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "0.67",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.57",
                            "ciUpperLimit": "1.92",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.63",
                            "estimateComment": "A positive mean difference indicates a treatment effect in favour of idalopirdine"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Behavioural Disturbance",
                    "description": "Change from baseline to Week 24 in Neuropsychiatric Inventory (NPI) total score\n\nThe Neuropsychiatric Inventory is a 12-item structured interview with a caregiver to assess behavioural disturbances. The NPI comprises 10 behavioural and 2 neurovegetative items. Each item consists of a screening question and several sub-questions that are rated no (not present) or yes (present). Each item is then rated for frequency (a 4-point scale from 1 \\[occasionally\\] to 4 \\[very frequent\\]) and severity (a 3-point scale from 1 \\[mild\\] to 3 \\[marked\\]). The total NPI score is the frequency ratings multiplied by the severity ratings and ranges from 0 to 144 (higher score indicates worse outcome).",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine, and who had a valid baseline assessment and at least one valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure assessed.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline and Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to base treatment with an AChEI\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 60 mg (or 30 mg)",
                            "description": "Idalopirdine adjunct to base treatment with an AChEI\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "356"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "361"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.46",
                                            "spread": "0.53"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.74",
                                            "spread": "0.54"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Individual Behavioural Disturbance Items",
                    "description": "Change in single NPI item scores at Week 24.\n\nThe Neuropsychiatric Inventory is a 12-item structured interview with a caregiver to assess behavioural disturbances. The NPI comprises 10 behavioural and 2 neurovegetative items. Each item consists of a screening question and several sub-questions that are rated no (not present) or yes (present). Each item is then rated for frequency (a 4-point scale from 1 \\[occasionally\\] to 4 \\[very frequent\\]) and severity (a 3-point scale from 1 \\[mild\\] to 3 \\[marked\\]). Total score for each single NPI item ranges from 0-12 (frequency multiplied by severity), where higher scores represent worse outcome.",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine and who had a valid baseline assessment and at least one valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure/item assessed",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline and Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to base treatment with an AChEI\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 60 mg (or 30 mg)",
                            "description": "Idalopirdine adjunct to base treatment with an AChEI\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "356"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "361"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Delusions",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.00",
                                            "spread": "0.10"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.03",
                                            "spread": "0.10"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Hallucinations",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.05",
                                            "spread": "0.06"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.08",
                                            "spread": "0.06"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Agitation/aggression",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.15",
                                            "spread": "0.11"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.03",
                                            "spread": "0.11"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Depression/dysphoria",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.28",
                                            "spread": "0.09"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.18",
                                            "spread": "0.09"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Anxiety",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.16",
                                            "spread": "0.09"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.07",
                                            "spread": "0.09"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Elation/euphoria",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.02",
                                            "spread": "0.04"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.03",
                                            "spread": "0.04"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Apathy/indifference",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.06",
                                            "spread": "0.15"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.19",
                                            "spread": "0.15"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Disinhibition",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.12",
                                            "spread": "0.08"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.00",
                                            "spread": "0.08"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Irritability/lability",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.10",
                                            "spread": "0.12"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.04",
                                            "spread": "0.12"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Aberrant motor behaviour",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.08",
                                            "spread": "0.11"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.11",
                                            "spread": "0.11"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Sleep",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.13",
                                            "spread": "0.11"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.12",
                                            "spread": "0.11"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Appetite/eating disorder",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.25",
                                            "spread": "0.12"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.21",
                                            "spread": "0.12"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in NPI Anxiety Item Score in Patients With an NPI Anxiety Item Score of at Least 2 at Baseline",
                    "description": "Change from baseline to Week 24 in NPI anxiety item score in patients with an NPI anxiety item score of at least 2 at baseline\n\nThe Neuropsychiatric Inventory is a 12-item structured interview with a caregiver to assess behavioural disturbances. The NPI comprises 10 behavioural and 2 neurovegetative items. Each item consists of a screening question and several sub-questions that are rated no (not present) or yes (present). Each item is then rated for frequency (a 4-point scale from 1 \\[occasionally\\] to 4 \\[very frequent\\]) and severity (a 3-point scale from 1 \\[mild\\] to 3 \\[marked\\]). The total score for the NPI anxiety item ranges from 0-12 (frequency multiplied by severity), where a higher score represents a worse outcome.",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine and who had a valid baseline assessment and at least one valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome/item measure assessed",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline and Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to base treatment with an AChEI\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 60 mg (or 30 mg)",
                            "description": "Idalopirdine adjunct to base treatment with an AChEI\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "86"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "83"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-1.93",
                                            "spread": "0.32"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-1.52",
                                            "spread": "0.33"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Clinical Improvement",
                    "description": "Clinical response at Week 24 (based on pre-specified ADAS-cog, ADCS-ADL23, and ADCS-CGIC changes \\[change in ADAS-cog below or equal to -4, change in ADCS-ADL23 at least 0, and ADCS-CGIC below or equal to 4\\])",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine, and who had a valid baseline assessment and at least one valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure assessed.",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to base treatment with an AChEI\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 60 mg (or 30 mg)",
                            "description": "Idalopirdine adjunct to base treatment with an AChEI\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "324"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "321"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "32"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "35"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Clinical Worsening",
                    "description": "Clinical worsening at Week 24 (Based on pre-specified ADAS-cog, ADCS-ADL23, and ADCS-CGIC changes \\[change in ADAS-cog above or equal to 4, change in ADCS-ADL23 below 0, and ADCS-CGIC above 4\\])",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine, and who had a valid baseline assessment and at least one valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure assessed.",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to base treatment with an AChEI\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 60 mg (or 30 mg)",
                            "description": "Idalopirdine adjunct to base treatment with an AChEI\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "324"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "321"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "37"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "40"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Cognitive Aspects of Mental Function",
                    "description": "Change from baseline to Week 24 in Mini Mental State Examination (MMSE).\n\nThe Mini Mental State Examination (MMSE) is an 11-item test to assess the cognitive aspects of mental function. The subtests assess orientation, memory, attention, language, and visual construction. The scores for each item is dichotomous (1 = response is correct, 0 = response is incorrect). Total score of the 11 items ranges from 0 to 30 (higher score indicates lower deficit).",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine, and who had a valid baseline assessment and at least one valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure assessed.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline and Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to base treatment with an AChEI\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 60 mg (or 30 mg)",
                            "description": "Idalopirdine adjunct to base treatment with an AChEI\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "323"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "320"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.64",
                                            "spread": "0.20"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.35",
                                            "spread": "0.20"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Health-related Quality of Life (EQ-5D) Utility Score",
                    "description": "Change from baseline to Week 24 in EuroQol 5-dimensional (EQ-5D) utility score\n\nThe EQ-5D is a patient-reported assessment that measures the patient's well-being. It consists of an utility score based on 5 descriptive items (mobility, self-care, usual activities, pain/discomfort, and depression/anxiety) and a Visual Analogue Scale (VAS). Each descriptive item is rated on a 3-point index ranging from 1 (no problems) to 3 (extreme problems) that is used for calculating a single summary index (from 0 to 1). A higher EQ-5D score indicates a worse outcome.",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine, and who had a valid baseline assessment and at least one valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure assessed.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline and Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to base treatment with an AChEI\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 60 mg (or 30 mg)",
                            "description": "Idalopirdine adjunct to base treatment with an AChEI\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "351"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "354"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.01",
                                            "spread": "0.01"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.00",
                                            "spread": "0.01"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Health-related Quality of Life (EQ-5D VAS)",
                    "description": "Change from baseline to Week 24 in EQ-5D Visual Analogue Scale (EQ-5D VAS).\n\nThe EQ-5D is a patient-reported assessment that measures the patient's well-being. It consists of an utility score based on 5 descriptive items (mobility, self-care, usual activities, pain/discomfort, and depression/anxiety) and a Visual Analogue Scale (VAS). The VAS ranges from 0 (worst imaginable health state) to 100 (best imaginable health state).",
                    "populationDescription": "All patients who took at least one dose of placebo or idalopirdine, and who had a valid baseline assessment and at least one valid post-baseline assessment of the primary outcome measure in the 24-week treatment period (Full-analysis Set). For secondary outcome measures, the number of participants who had the respective outcome measure assessed.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "units on a scale",
                    "timeFrame": "Baseline and Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Placebo adjunct to base treatment with an AChEI\n\nPlacebo: Once daily, matching placebo capsules, orally"
                        },
                        {
                            "id": "OG001",
                            "title": "Idalopirdine 60 mg (or 30 mg)",
                            "description": "Idalopirdine adjunct to base treatment with an AChEI\n\nIdalopirdine: Once daily, encapsulated tablets, orally"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "351"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "353"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.40",
                                            "spread": "1.00"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.51",
                                            "spread": "1.02"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "5",
            "timeFrame": "Baseline to end of study",
            "description": "Treatment-Emergent Adverse Events are reported in this section",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "Placebo",
                    "description": "Placebo adjunct to base treatment with an AChEI\n\nPlacebo: Once daily, matching placebo capsules, orally",
                    "deathsNumAffected": 1,
                    "deathsNumAtRisk": 365,
                    "seriousNumAffected": 22,
                    "seriousNumAtRisk": 365,
                    "otherNumAffected": 64,
                    "otherNumAtRisk": 365
                },
                {
                    "id": "EG001",
                    "title": "Idalopirdine 60 mg",
                    "description": "Idalopirdine adjunct to base treatment with an AChEI\n\nIdalopirdine: Once daily, encapsulated tablets, orally",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 363,
                    "seriousNumAffected": 28,
                    "seriousNumAtRisk": 363,
                    "otherNumAffected": 82,
                    "otherNumAtRisk": 363
                }
            ],
            "seriousEvents": [
                {
                    "term": "Bradycardia",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Left ventricular failure",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Myocardial infarction",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 2,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Retinal detachment",
                    "organSystem": "Eye disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Colitis ulcerative",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Gastrointestinal inflammation",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Nausea",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Pancreatitis acute",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Vomiting",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Chest pain",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Cholelithiasis",
                    "organSystem": "Hepatobiliary disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Drug-induced liver injury",
                    "organSystem": "Hepatobiliary disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Diverticulitis",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Erysipelas",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Gastroenteritis viral",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Pneumonia bacterial",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Urinary tract infection bacterial",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Acetabulum fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Clavicle fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Concussion",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Fall",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 5,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Femoral neck fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Femur fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Head injury",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Hip fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Laceration",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 2,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Lumbar vertebral fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Pubis fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Rib fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Road traffic accident",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Subdural haematoma",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Traumatic intracranial haemorrhage",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Electrocardiogram st segment depression",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Gout",
                    "organSystem": "Metabolism and nutrition disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Hypokalaemia",
                    "organSystem": "Metabolism and nutrition disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Basal cell carcinoma",
                    "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Cervix carcinoma",
                    "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 234
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 228
                        }
                    ]
                },
                {
                    "term": "Glioblastoma multiforme",
                    "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Cerebral haematoma",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Cerebral haemorrhage",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Dizziness",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Generalised tonic-clonic seizure",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Intracranial haematoma",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Ischaemic stroke",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Lethargy",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Loss of consciousness",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Partial seizures",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Syncope",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Agitation",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Behavioural and psychiatric symptoms of dementia",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Personality disorder",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Azotaemia",
                    "organSystem": "Renal and urinary disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Subcutaneous emphysema",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Hypertension",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 2,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Hypertensive emergency",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Internal haemorrhage",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Peripheral vascular disorder",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Peripheral venous disease",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 363
                        }
                    ]
                }
            ],
            "otherEvents": [
                {
                    "term": "Accidental overdose",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 43,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 40,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Fall",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 21,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 19,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Aspartate aminotransferase increased",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 3,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 19,
                            "numAtRisk": 363
                        }
                    ]
                },
                {
                    "term": "Gamma-glutamyltransferase increased",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA 19.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 2,
                            "numAtRisk": 365
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 22,
                            "numAtRisk": 363
                        }
                    ]
                }
            ]
        },
        "moreInfoModule": {
            "certainAgreement": {
                "piSponsorEmployee": false,
                "restrictiveAgreement": false
            },
            "pointOfContact": {
                "title": "Email contact via",
                "organization": "H. Lundbeck A/S",
                "email": "LundbeckClinicalTrials@lundbeck.com",
                "phone": "+4536301311"
            }
        }
    },
    "target_category": "cognitive enhancer",
    "drug": [
        "Idalopirdine (Lu AE58054) \u2014 selective 5\u2011HT6 receptor antagonist"
    ],
    "placebo": [
        "Placebo (matching)"
    ],
    "explanation_target": [
        "Reason: The trial tests idalopirdine as an adjunct to acetylcholinesterase inhibitors for symptomatic treatment of mild\u2013moderate Alzheimer disease, which indicates the goal is to improve cognition/symptoms rather than to modify core AD pathology (amyloid/tau). Idalopirdine is described in the literature as a selective serotonin 5\u2011HT6 receptor antagonist (a small molecule) developed to enhance cognitive function. \ue200cite\ue202turn0search1\ue202turn0search0\ue201.",
        "Act: Key extracted details \u2014 drug name and type: idalopirdine (Lu AE58054), a small\u2011molecule selective 5\u2011HT6 receptor antagonist; intervention: idalopirdine added to standard AChEI therapy versus placebo; intended effect: symptomatic cognitive improvement (adjunctive cognitive enhancer). These characterizations are supported by phase 2 and phase 3 trial reports and mechanistic studies. \ue200cite\ue202turn0search4\ue202turn0search0\ue201.",
        "Reflect: Classification decision \u2014 fits the definition of 'Cognitive enhancer' (category 3): a small\u2011molecule agent intended to improve cognition without directly targeting amyloid or tau pathology. Note: large phase III programs ultimately did not meet prespecified efficacy endpoints, but that outcome does not change the intended mechanism/classification. \ue200cite\ue202turn0search2\ue202turn0search6\ue201."
    ],
    "agent_type": "D) Neurotransmitter Receptors",
    "explanation_agent": [
        "Reason: The investigational drug idalopirdine (Lu AE58054) is a selective serotonin 5\u2011HT6 receptor antagonist \u2014 a ligand acting on a neurotransmitter receptor \u2014 and the trial tests it as an adjunctive symptomatic cognitive enhancer in mild\u2013moderate Alzheimer disease rather than as an anti-amyloid or anti\u2011tau disease\u2011modifying agent. \ue200cite\ue202turn0search3\ue202turn0search5\ue201",
        "Act: Key extracted details and mapping to CADRO \u2014 drug: idalopirdine (Lu AE58054); mechanism: selective 5\u2011HT6 (serotonin) receptor antagonism; intervention: adjunct to acetylcholinesterase inhibitor for symptomatic cognitive improvement in mild\u2013moderate AD. These facts support assignment to CADRO category D) Neurotransmitter Receptors. Trial registry and outcome summaries describe the phase\u20113 adjunct trials and their null efficacy results. \ue200cite\ue202turn0search0\ue202turn0search6\ue202turn0search1\ue201",
        "Reflect: The 5\u2011HT6 receptor is explicitly a neurotransmitter receptor, so the most specific CADRO category is D) Neurotransmitter Receptors. The intervention is symptomatic (cognitive enhancement) and does not target amyloid, tau, inflammation, or other CADRO categories \u2014 nor does it indicate multiple distinct mechanistic targets \u2014 so 'D' is the appropriate classification. Relevant clinical trial publications and reviews confirm the mechanism and clinical context. \ue200cite\ue202turn0search4\ue202turn0search1\ue201",
        "Web search results (sources used): 1) ClinicalTrials.gov study record for the phase\u20113 trial 'Study of Idalopirdine in Patients With Mild - Moderate Alzheimer\u2019s Disease\u2026' (trial details: adjunctive to AChEIs, 24\u2011week double\u2011blind). \ue200cite\ue202turn0search0\ue201 2) JAMA report summarizing three randomized trials showing idalopirdine did not improve cognition vs placebo in mild\u2013moderate AD. \ue200cite\ue202turn0search1\ue201 3) Pharmacology/microdialysis study and reviews describing idalopirdine as a high\u2011affinity selective 5\u2011HT6 receptor antagonist and its effects on monoamines/glutamate relevant to cognitive modulation. \ue200cite\ue202turn0search3\ue202turn0search5\ue201 4) Systematic review/meta\u2011analysis of idalopirdine RCTs summarizing efficacy and safety. \ue200cite\ue202turn0search4\ue201"
    ]
}